Join us on October 5

Phyllis Ferrell is the Global Head of External Engagement for Alzheimer’s disease and Neurodegeneration at Eli Lilly & Company, where she previously served as the leader of the Global Alzheimer’s disease development team. She also currently serves on secondment as the Acting Director of the Davos Alzheimer’s Collaborative Healthcare System Preparedness initiative. Ferrell received a Bachelor of Arts degree in economics and management from DePauw University and received an MBA in general management and a certificate in public management from the Stanford University Graduate School of Business in 2001.

Phyllis is a current member of the World Dementia Council, an advisory committee member of the Milken Institute Center for Future of Aging and the USC Clinical Trial Recruiting Laboratory, and a strategic reviewer for the Alzheimer’s Disease Drug Discovery Foundation Diagnostics Accelerator. Phyllis is also on the Boards of Directors for Alzheimer’s Research UK EDoN, Gates Ventures Alzheimer’s Disease Data Initiative, the Indiana Chapter of the Alzheimer’s Association, and the Indianapolis 500 Festival. Phyllis is a founding member of Women Against Alzheimer’s and Women of Impact Boone County; co-chair of the Women’s Leadership Council and the alumna sponsor of the Women in Economics and Business Program at DePauw University. Phyllis is passionate about Alzheimer’s advocacy and inclusion so that other boys don’t have to grow up without their grandfathers’ presence as her sons did.

Key Updates for the Down Syndrome Community: 5 Takeaways About Accessing the new Alzheimer’s Drugs 

Alzheimer’s Drugs Are Here. But for the Down Syndrome Community It’s Still the 1980s .

LuMind IDSC Launches Key Research and Awareness Activities with Support from Eli Lilly and Company 

“For People With Down Syndrome, A Longer Life, But Under A Cloud” by the Washington Post 

Sign The Petition: Equity For Our Community: Today and Tomorrow